Abstract:BACKGROUND: Atherosclerosis is a globally prevalent chronic inflammatory disease with high morbidity and mortality. The development of atherosclerotic lesions is determined by macrophages. This study aimed to investigate the specific role of myeloid-derived CD147 (cluster of differentiation 147) in atherosclerosis and its translational significance. METHODS AND RESULTS: We generated mice with a myeloid-specific knockout of CD147 and mice with restricted CD147 overexpression, both in an apoE-deficient (ApoE –/– ) background. Here, the myeloid-specific deletion of CD147 ameliorated atherosclerosis and inflammation. Consistent with our in vivo data, macrophages isolated from myeloid-specific CD147 knockout mice exhibited a phenotype shift from proinflammatory to anti-inflammatory macrophage polarization in response to lipopolysaccharide/IFN (interferon)-γ. These macrophages demonstrated a weakened proinflammatory macrophage phenotype, characterized by reduced production of NO and reactive nitrogen species derived from iNOS (inducible NO synthase). Mechanistically, the TRAF6 (tumor necrosis factor receptor–associated factor 6)-IKK (inhibitor of κB kinase)-IRF5 (IFN regulatory factor 5) signaling pathway was essential for the effect of CD147 on proinflammatory responses. Consistent with the reduced size of the necrotic core, myeloid-specific CD147 deficiency diminished the susceptibility of iNOS-mediated late apoptosis, accompanied by enhanced efferocytotic capacity mediated by increased secretion of GAS6 (growth arrest–specific 6) in proinflammatory macrophages. These findings were consistent in a mouse model with myeloid-restricted overexpression of CD147. Furthermore, we developed a new atherosclerosis model in ApoE –/– mice with humanized CD147 transgenic expression and demonstrated that the administration of an anti-human CD147 antibody effectively suppressed atherosclerosis by targeting inflammation and efferocytosis. CONCLUSIONS: Myeloid CD147 plays a crucial role in the growth of plaques by promoting inflammation in a TRAF6-IKK-IRF5–dependent manner and inhibiting efferocytosis by suppressing GAS6 during proinflammatory conditions. Consequently, the use of anti-human CD147 antibodies presents a complementary therapeutic approach to the existing lipid-lowering strategies for treating atherosclerotic diseases.

Decreased ERK and JNK Signaling Contribute to Gene Overexpression in “senescent” CD4+CD28– T Cells Through Epigenetic Mechanisms

Decreased Dna Methyltransferase Levels Contribute to Abnormal Gene Expression in "senescent" Cd4(+)Cd28(-) T Cells

Abstract 105: Lipid Regulation of Senescent Effector CD8 T Cells in Type 2 Diabetes

CD70 Contributes to Age-Associated T Cell Defects and Overwhelming Inflammatory Responses

Abstract 108: Inflammasome Activation Via BRCC3-mediated NLRP3 Deubiquitylation Promotes Atherosclerosis in Tet2 Clonal Hematopoiesis

Deficient Activity of the Nuclease Mre11a Induces T Cell Aging and Promotes Arthritogenic Effector Functions in Patients with Rheumatoid Arthritis

Cytoplasmic DNA sensing by KU complex in aged CD4+ T cell potentiates T cell activation and aging-related autoimmune inflammation

Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence

Investigation of Signaling in Primary Populations of Human Senescent T Cells

Inflammatory Crosstalk Impairs Phagocytic Receptors and Aggravates Atherosclerosis in Clonal Hematopoiesis in Mice

Cellular senescence promotes endothelial activation through epigenetic alteration, and consequently accelerates atherosclerosis

Hyperexpression of Tumor Necrosis Factor Receptor 2 Inhibits Differentiation of Myeloid‐derived Suppressor Cells by Instigating Apolarity During Ageing

Molecular basis of age-associated cytokine dysregulation in LPS-stimulated macrophages

Epigenetic upregulation of FKBP5 by aging and stress contributes to NF-κB–driven inflammation and cardiovascular risk

Functional pathways regulated by microRNA networks in CD8 T-cell aging

Age-related Changes in Expression and Signaling of TAM Receptor Inflammatory Regulators in Monocytes

CD147 Sparks Atherosclerosis by Driving M1 Phenotype and Impairing Efferocytosis

The Alternation of Autophagy/apoptosis in CD4+CD25+Foxp3+ Tregs on the Developmental Stages of Atherosclerosis.

DNA damage drives accelerated bone aging via an NF-κB-dependent mechanism

Type 2 cytokine signaling in macrophages protects from cellular senescence and organismal aging

Abstract Tu014: Endoplasmic reticulum stress exacerbates atherosclerosis via microRNA-181a by inhibiting mitophagy